Exploring the Potential Drug Target and Biomarker LOC644189 (Acyl-CoA Thioesterase 4 Pseudogene)

Exploring the Potential Drug Target and Biomarker LOC644189 (Acyl-CoA Thioesterase 4 Pseudogene)

Acyl-CoA thioesterase 4 (LOC644189) is a protein that plays a crucial role in the regulation of fatty acid metabolism in the body. It is a pseudogene, which means that it encodes a protein that is similar to the gene encoding the enzyme acyl-CoA thioesterase 4. LOC644189 is expressed in various tissues and cells throughout the body, including liver, muscle, and brain, making it a potential drug target and biomarker. In this article, we will explore the potential drug target and biomarker properties of LOC644189.

Potential Drug Target

LOC644189 is a key enzyme in the fatty acid metabolism pathway, which is involved in the production of fatty acids from Carbohydrates. It is a critical enzyme for the synthesis of the 18-carbon fatty acid, which is the most abundant fatty acid in the body. LOC644189 is known to be involved in the regulation of the synthesis of fatty acids from the carbonyl group (Acyl-CoA) thioesterate.

The 18-carbon fatty acid is an essential component of the cell membrane and plays a crucial role in various cellular processes, including brain function, hormone signaling, and inflammation. However, an imbalance in the synthesis of 18-carbon fatty acids can lead to a range of health problems, including obesity, diabetes, and certain neurological disorders.

LOC644189 has been identified as a potential drug target due to its involvement in the regulation of 18-carbon fatty acid synthesis. Activating LOC644189 has been shown to increase the rate of 18-carbon fatty acid synthesis, while inhibiting its activity has been shown to decrease the rate of 18-carbon fatty acid synthesis.

Biomarker

LOC644189 has also been identified as a potential biomarker for various diseases, including obesity, type 2 diabetes, and certain neurological disorders. Obesity, type 2 diabetes, and certain neurological disorders are characterized by an imbalance in the levels of 18-carbon fatty acids.

For example, obesity is characterized by an imbalance in the production of 18-carbon fatty acids from Carbohydrates. This leads to an accumulation of 18-carbon fatty acids in the body, which can lead to the development of obesity. Similarly, type 2 diabetes is characterized by an imbalance in the breakdown of 18-carbon fatty acids, leading to an accumulation of 18-carbon fatty acids in the body.

LOC644189 has also been shown to be involved in the regulation of 18-carbon fatty acid synthesis in certain neurological disorders, such as Alzheimer's disease and Parkinson's disease. These disorders are characterized by an imbalance in the production and breakdown of 18-carbon fatty acids, leading to the development of neurodegeneration.

Conclusion

LOC644189 is a pseudogene that encodes a protein involved in the regulation of fatty acid metabolism. It has been identified as a potential drug target due to its involvement in the production of 18-carbon fatty acids and as a potential biomarker for various diseases, including obesity, type 2 diabetes, and certain neurological disorders. Further research is needed to fully understand the role of LOC644189 in fatty acid metabolism and its potential as a drug target and biomarker.

Protein Name: Acyl-CoA Thioesterase 4 Pseudogene

The "LOC644189 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC644189 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC644215 | LOC644277 | LOC644525 | LOC644584 | LOC644634 | LOC644656 | LOC644662 | LOC644669 | LOC644893 | LOC644936 | LOC645086 | LOC645181 | LOC645188 | LOC645266 | LOC645468 | LOC645503 | LOC645967 | LOC646044 | LOC646214 | LOC646358 | LOC646471 | LOC646674 | LOC646736 | LOC646762 | LOC646813 | LOC646836 | LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2 | LONRF1 | LONRF2 | LONRF3 | LORICRIN